Rezolute, Inc. Common Stock (NV)
RZLT Real Time Price USDRecent trades of RZLT by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by RZLT's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Crystalline forms of plasma kallikrein inhibitors Apr. 19, 2022
-
Patent Title: Processes for preparing plasma kallikrein inhibitors Mar. 08, 2022
-
Patent Title: Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates Jul. 07, 2020
-
Patent Title: Coiled tube emulsification systems Feb. 18, 2020
-
Patent Title: Amine pegylation methods for the preparation of site-specific protein conjugates Mar. 05, 2019
-
Patent Title: Solvent extraction from biodegradable microparticles Nov. 27, 2018
-
Patent Title: Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates Aug. 14, 2018
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of RZLT in WallStreetBets Daily Discussion
Recent insights relating to RZLT
Recent picks made for RZLT stock on CNBC
ETFs with the largest estimated holdings in RZLT
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view RZLT Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.